Reply by Authors
J Urol
.
2021 Oct;206(4):969.
doi: 10.1097/JU.0000000000001790.02.
Epub 2021 Aug 11.
Authors
Nicholas H Chakiryan
1
,
Aaron Dahmen
2
,
Marco Bandini
3
,
Filippo Pederzoli
3
,
Laura Marandino
4
,
Maarten Albersen
5
,
Eduard Roussel
5
,
Yao Zhu
6
,
Ding-Wei Ye
6
,
Antonio A Ornellas
7
,
Mario Catanzaro
4
,
Oliver W Hakenberg
8
,
Axel Heidenreich
9
,
Friederike Haidl
9
,
Nick Watkin
9
,
Michael Ager
9
,
Jad Chahoud
1
,
Alberto Briganti
3
,
Roberto Salvioni
4
,
Francesco Montorsi
3
,
Andrea Necchi
4
,
Philippe E Spiess
1
Affiliations
1
H. Lee Moffitt Cancer Center, Department of Genitourinary Oncology, Tampa, Florida.
2
University of South Florida, Department of Urology, Tampa, Florida.
3
Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
4
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
5
University Hospitals Leuven, Leuven, Belgium.
6
Fudan University Shanghai Cancer Center, Shanghai, China.
7
Hospital Mário Kröeff and Brazilian Cancer Institute, Rio de Janeiro, Brazil.
8
University Hospital Rostock, Rostock, Germany.
9
Universitätsklinikum Köln, Köln, Germany.
PMID:
34379451
DOI:
10.1097/JU.0000000000001790.02
No abstract available
Publication types
Comment